AR058141A1 - Composiciones topicas de n,2,3 -trimetil-2- isopropilbutamida para el alivio del dolor y metodos para usarlas - Google Patents

Composiciones topicas de n,2,3 -trimetil-2- isopropilbutamida para el alivio del dolor y metodos para usarlas

Info

Publication number
AR058141A1
AR058141A1 ARP060104625A ARP060104625A AR058141A1 AR 058141 A1 AR058141 A1 AR 058141A1 AR P060104625 A ARP060104625 A AR P060104625A AR P060104625 A ARP060104625 A AR P060104625A AR 058141 A1 AR058141 A1 AR 058141A1
Authority
AR
Argentina
Prior art keywords
pain relief
trimethyl
methods
isopropilbutamide
compositions
Prior art date
Application number
ARP060104625A
Other languages
English (en)
Original Assignee
Teikoku Pharma Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teikoku Pharma Usa Inc filed Critical Teikoku Pharma Usa Inc
Publication of AR058141A1 publication Critical patent/AR058141A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Composiciones topicas para el alivio del dolor de N,2,3-trimetil-2-isopropilbutanamida, y métodos para usarlas. Las composiciones incluyen una cantidad efectiva para el alivio del dolor de N,2,3-trimetil-2-isopropilbutanamida en una formulacion topica, por ejemplo un parche, gel, crema o espuma. También se presentan métodos pata usar las composiciones en aplicaciones de alivio del dolor.
ARP060104625A 2005-10-24 2006-10-23 Composiciones topicas de n,2,3 -trimetil-2- isopropilbutamida para el alivio del dolor y metodos para usarlas AR058141A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72984405P 2005-10-24 2005-10-24

Publications (1)

Publication Number Publication Date
AR058141A1 true AR058141A1 (es) 2008-01-23

Family

ID=37968368

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060104625A AR058141A1 (es) 2005-10-24 2006-10-23 Composiciones topicas de n,2,3 -trimetil-2- isopropilbutamida para el alivio del dolor y metodos para usarlas

Country Status (15)

Country Link
US (1) US20070093555A1 (es)
EP (1) EP1940377A4 (es)
JP (2) JP5128483B2 (es)
KR (1) KR20080035637A (es)
CN (1) CN101534805A (es)
AR (1) AR058141A1 (es)
AU (1) AU2006306563B2 (es)
BR (1) BRPI0613067A2 (es)
CA (1) CA2614345C (es)
MX (1) MX2008000486A (es)
NZ (1) NZ564014A (es)
RU (1) RU2407522C2 (es)
TW (1) TWI372047B (es)
WO (1) WO2007050369A2 (es)
ZA (1) ZA200711041B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008000486A (es) * 2005-10-24 2008-03-07 Teikoku Pharma Usa Inc Composiciones topicas para el alivio del dolor de n-2,3-trimetil-2-isopropilbutamida y metodos para usar las mismas.
WO2011133177A1 (en) * 2010-04-21 2011-10-27 Teikoku Pharma Usa, Inc. Local anesthetic emulsion compositions and methods of making and using the same
KR101827980B1 (ko) 2013-10-07 2018-02-13 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치 및 이의 사용 방법
KR101831290B1 (ko) 2013-10-07 2018-02-22 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 조성물을 사용하여 주의력 결핍 과잉행동 장애, 불안 및 불면증을 치료하기 위한 방법 및 조성물
ES2847936T3 (es) 2013-10-07 2021-08-04 Teikoku Pharma Usa Inc Métodos y composiciones para el suministro transdérmico de una cantidad no sedante de dexmedetomidina
US20160158393A1 (en) * 2014-02-21 2016-06-09 Avadim Technologies, Inc. Method for Improving Health Outcomes
EP3107612A1 (en) 2014-02-21 2016-12-28 Avadim Technologies, Inc. Method for maintenance of urethral catheters
KR102621024B1 (ko) * 2023-09-12 2024-01-05 (주)진코스텍 심미감 및 피부 흡수력이 개선된 하이드로겔 패치

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH10359A (en) * 1971-02-04 1977-01-05 Wilkinson Sword Ltd N-substituted-p-methane-3-carboxamides having physiological cooling activity and compositions containing them
US4193936A (en) 1971-02-04 1980-03-18 Wilkinson Sword Limited N-substituted paramenthane carboxamides
US4150052A (en) 1971-02-04 1979-04-17 Wilkinson Sword Limited N-substituted paramenthane carboxamides
US4059118A (en) 1972-01-28 1977-11-22 Wilkinson Sword Limited Tobacco and tobacco-containing manufactures containing an ingredient having physiological cooling activity
US4033994A (en) 1972-01-28 1977-07-05 Wilkinson Sword Limited Substituted p-menthanes
US4060091A (en) * 1972-01-28 1977-11-29 Wilkinson Sword Limited Tobacco and tobacco-containing manufactures containing an ingredient having physiological cooling activity
GB1421743A (en) * 1972-04-18 1976-01-21 Wilkinson Sword Ltd Ingestible topical and other compositions
US4153679A (en) 1972-04-18 1979-05-08 Wilkinson Sword Limited Acyclic carboxamides having a physiological cooling effect
CA1027347A (en) 1972-07-20 1978-03-07 David G. Rowsell Compounds having a physiological cooling effect and compositions containing them
BE802469A (fr) * 1972-07-20 1974-01-18 Wilkinson Sword Ltd Perfectionnements apportes et/ou relatifs a des composes exercant un effet refrigerant physiologique et compositions contenant ceux-ci
GB1434728A (en) 1972-09-27 1976-05-05 Wilkinson Sword Ltd Compositions and articles containing phospine oxides having a physiological cooling effect and phosphine oxides for use therein
US4070449A (en) 1972-10-24 1978-01-24 Wilkinson Sword Limited Compounds having a physiological cooling effect and compositions containing them
US4034109A (en) * 1973-01-18 1977-07-05 Wilkinson Sword Limited Compounds having a physiological cooling effect and compositions containing them
US4296093A (en) * 1973-04-16 1981-10-20 Wilkinson Sword Limited Cyclic carboxamides having a physiological cooling effect
US4172887A (en) * 1973-11-30 1979-10-30 L'oreal Hair conditioning compositions containing crosslinked polyaminopolyamides
JPS5888334A (ja) 1981-11-20 1983-05-26 Takasago Corp ３−ｌ−メントキシプロパン−１、２−ジオ−ル
US5120544A (en) 1989-06-19 1992-06-09 Henley International, Inc. Crosslinked hydrogel and method for making same
US5270358A (en) 1989-12-28 1993-12-14 Minnesota Mining And Manufacturing Company Composite of a disperesed gel in an adhesive matrix
US5148804A (en) * 1990-06-28 1992-09-22 Hill Dennis M Device, system, and methods for applying cryotherapy
JP3115625B2 (ja) 1991-03-30 2000-12-11 帝國製薬株式会社 リドカイン含有外用貼付剤
DE4110973A1 (de) * 1991-04-05 1992-10-08 Haarmann & Reimer Gmbh Mittel mit physiologischem kuehleffekt und fuer diese mittel geeignete wirksame verbindungen
US5160328A (en) 1991-08-07 1992-11-03 Ndm Acquisition Corp. Hydrogel bandage
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
ES2105293T3 (es) * 1992-06-17 1997-10-16 Procter & Gamble Composiciones refrescantes con efecto irritante reducido.
DE69411726T2 (de) * 1993-04-30 1999-02-11 Procter & Gamble Zusammensetzungen zur freigabe einer aromatischen substanz in die nase
US5760085A (en) * 1993-04-30 1998-06-02 The Procter & Gamble Company Topical aromatic releasing compositions
US5423737A (en) 1993-05-27 1995-06-13 New Dimensions In Medicine, Inc. Transparent hydrogel wound dressing with release tab
NZ250994A (en) 1993-05-27 1995-09-26 Ndm Acquisition Corp Wound dressing comprising a hydrogel layer bound to a porous backing layer which is bound to a thin film layer by adhesive
JP2978043B2 (ja) 1993-09-16 1999-11-15 高砂香料工業株式会社 （２ｓ）−３−｛（１ｒ，２ｓ，５ｒ）−［ ５−メチル−２−（１−メチルエチル）シクロヘキシル ］オキシ｝−１，２−プロパンジオール，その製造方法および用途
US5407665A (en) * 1993-12-22 1995-04-18 The Procter & Gamble Company Ethanol substitutes
US5536263A (en) 1994-03-30 1996-07-16 Lectec Corporation Non-occulusive adhesive patch for applying medication to the skin
JP3241542B2 (ja) * 1994-07-29 2001-12-25 高砂香料工業株式会社 （−）−ｎ−イソプレゴールの精製方法及びその方法で得られた（−）−ｎ−イソプレゴールを含有するシトラス系香料組成物
EP0782861B1 (en) * 1994-10-05 2001-12-12 Hisamitsu Pharmaceutical Co., Inc. Drug compounding ingredients comprising n-substituted-o-toluidine derivative and percutaneously absorbable preparation
DE69625549T2 (de) * 1995-06-27 2003-05-15 Kao Corp Pflaster mit wasserlöslicher Klebeschicht
US6039940A (en) 1996-10-28 2000-03-21 Ballard Medical Products Inherently antimicrobial quaternary amine hydrogel wound dressings
US6769428B2 (en) * 1997-01-29 2004-08-03 Peter J. Cronk Adhesively applied external nasal strips and dilators containing medications and fragrances
US6244265B1 (en) * 1997-01-29 2001-06-12 Peter J. Cronk Adhesively applied external nasal strips and dilators containing medications and fragrances
US6120803A (en) * 1997-08-11 2000-09-19 Alza Corporation Prolonged release active agent dosage form adapted for gastric retention
US6455080B1 (en) * 1997-12-29 2002-09-24 Wm. Wrigley Jr., Company Chewing gum containing controlled release acyclic carboxamide and method of making
JP3450680B2 (ja) * 1997-10-28 2003-09-29 高砂香料工業株式会社 パラ−メンタン−３，８−ジオールの製造方法
US20020013304A1 (en) * 1997-10-28 2002-01-31 Wilson Leland F. As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness
DE69808126T3 (de) * 1997-11-27 2006-11-23 Firmenich S.A. Mentholderivate und ihre anwendung als erfrischungsmittel
JP4017758B2 (ja) 1998-08-04 2007-12-05 高砂香料工業株式会社 冷感剤組成物
US6656456B2 (en) 1998-11-23 2003-12-02 The Procter & Gamble Company Skin deodorizing compositions
US6183766B1 (en) * 1999-02-12 2001-02-06 The Procter & Gamble Company Skin sanitizing compositions
ATE382270T1 (de) * 1999-03-31 2008-01-15 Firmenich & Cie Verwendung von cubebol als aromastoff
US6267974B1 (en) * 1999-04-16 2001-07-31 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Cosmetic compositions with sensate mixtures based on isopulegol
US6455065B1 (en) 1999-05-18 2002-09-24 Lectec Corporation Therapeutic method for treating acne or isolated pimples and adhesive patch therefor
US6348212B2 (en) 1999-05-18 2002-02-19 Lectec Corporation Treating traumatic burns or blisters of the skin
US6296869B1 (en) 1999-07-30 2001-10-02 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Adhesive cosmetic patch containing alpha or beta hydroxy acids
WO2001017472A1 (en) * 1999-09-08 2001-03-15 Watson Pharmaceuticals, Inc. Using quaternary ammonium salts for transdermal drug delivery
RU2219902C1 (ru) * 1999-11-12 2003-12-27 Дзе Проктер Энд Гэмбл Компани Оральная композиция, имеющая противомикробную активность для уменьшения зубного налета и лечения гингивита (варианты), способ уменьшения зубного налета и лечения гингивита
US6677391B1 (en) * 1999-12-08 2004-01-13 The Procter & Gamble Company Tartar control denture adhesive compositions
ATE380474T1 (de) 2000-05-23 2007-12-15 Nestle Sa Verwendung von alpha-ketoenaminderivaten als kühlende mittel
US6649178B2 (en) * 2000-06-13 2003-11-18 Fatemeh Mohammadi Cosmetic composition for stressed skin under extreme conditions
US6497859B1 (en) * 2000-11-17 2002-12-24 Noville Inc. Cooling agents, pharmaceutical compositions having cooling agents and processes for making and using same
US6391886B1 (en) * 2000-12-04 2002-05-21 The Procter & Gamble Company Oral compositions having improved consumer aesthetics
US20020143047A1 (en) * 2001-01-05 2002-10-03 Galer Bradley S. Methods for treating indomethacin responsive headaches
US6761900B2 (en) * 2001-03-12 2004-07-13 Teikoku Pharma Usa, Inc. Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
US6514484B2 (en) * 2001-03-19 2003-02-04 The Procter & Gamble Company Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier
EP1245240A1 (en) 2001-03-30 2002-10-02 The Procter & Gamble Company Skin-compatible hydrogel adhesives and personal care products containing them
DE60229745D1 (de) * 2001-06-25 2008-12-18 Procter & Gamble Mundpflegezusammensetzungen
US20030175328A1 (en) * 2002-03-06 2003-09-18 Adi Shefer Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin
JP2004059474A (ja) 2002-07-26 2004-02-26 T Hasegawa Co Ltd ｐ−メンタン誘導体およびこれを含有する冷感剤
GB0221697D0 (en) * 2002-09-18 2002-10-30 Unilever Plc Novel compouds and their uses
GB0315974D0 (en) * 2003-07-08 2003-08-13 Coolanalgesia Ltd Cooling device for pain relief
US8062661B2 (en) * 2003-12-11 2011-11-22 Teikoku Pharma Usa, Inc. Methods and compositions for treating skin wounds
US7482378B2 (en) * 2004-05-28 2009-01-27 Millenium Specialty Chemicals, Inc. Physiological cooling compositions
BRPI0519748A2 (pt) * 2005-01-04 2009-03-10 Teikoku Pharma Usa Inc preparaÇço de curativo para resfriamento tàpico
US20070259354A1 (en) * 2005-10-11 2007-11-08 Senomyx, Inc. Optimized trpm8 nucleic acid sequences and their use in cell based assays and test kits to identify trpm8 modulators
MX2008000486A (es) * 2005-10-24 2008-03-07 Teikoku Pharma Usa Inc Composiciones topicas para el alivio del dolor de n-2,3-trimetil-2-isopropilbutamida y metodos para usar las mismas.
US20070185237A1 (en) * 2005-11-09 2007-08-09 Jayanth Rajaiah Denture adhesive articles

Also Published As

Publication number Publication date
US20070093555A1 (en) 2007-04-26
NZ564014A (en) 2011-10-28
BRPI0613067A2 (pt) 2010-12-21
AU2006306563B2 (en) 2009-10-01
TW200731965A (en) 2007-09-01
EP1940377A2 (en) 2008-07-09
ZA200711041B (en) 2009-08-26
AU2006306563A1 (en) 2007-05-03
JP2012197301A (ja) 2012-10-18
CA2614345A1 (en) 2007-05-03
TWI372047B (en) 2012-09-11
KR20080035637A (ko) 2008-04-23
EP1940377A4 (en) 2010-12-08
RU2008117760A (ru) 2009-12-10
CN101534805A (zh) 2009-09-16
JP5128483B2 (ja) 2013-01-23
MX2008000486A (es) 2008-03-07
RU2407522C2 (ru) 2010-12-27
JP2009515829A (ja) 2009-04-16
WO2007050369A3 (en) 2009-04-30
WO2007050369A2 (en) 2007-05-03
JP5508477B2 (ja) 2014-05-28
CA2614345C (en) 2013-01-08

Similar Documents

Publication Publication Date Title
AR058141A1 (es) Composiciones topicas de n,2,3 -trimetil-2- isopropilbutamida para el alivio del dolor y metodos para usarlas
AR048878A1 (es) Composiciones topicas de metadona y metodos para usarlas
BRPI0516857A (pt) dispositivos biomédicos que contêm copolìmeros de bloco anfifìlico
CY1114048T1 (el) Συνδυασμος βριμονιδινης και τιμολολης για τοπικη οφθαλμικη χρηση
RS51569B (en) COMPOSITIONS CONTAINING CRYSTAL TRANS - (+/-) - DELTA-9-TETRAHYDROCANABINOL
GT200600520A (es) Agentes antibacterianos
CR9351A (es) Composiciones y metodos para aplicaicon topica y suministro transdermico de toxina botulinica
CL2011003160A1 (es) Compuestos derivados de heterociclicos, moduladores cb2; composicion farmaceutica que los comprende; y uso en el tratamiento de enfermedades reumaticas, autoinmune, inflamatorias, dolor, entre otras.
BRPI0511396A (pt) derivados de retinal e métodos para uso no tratamento de enfermidades visuais
UY29796A1 (es) Nuevos compuestos para el tratamiento de trastornos neurológicos, psiquiátricos o del dolor
MX2009009463A (es) Preparacion de una pelicula de rapida disolucion/desintegracion que tiene una alta proporcion de ingrediente activo.
MX2010003258A (es) Utilizacion de un nuevo agente natural en composiciones cosmeticas.
PT1411908E (pt) Tratamento de infeccoes da unha com no
NI201000044A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
MX2009012645A (es) Formulaciones y metodos para tratar el ojo seco.
CL2008000442A1 (es) Composicion farmaceutica que comprende a un quitosano, un ingrediente activo cosmetico o farmaceutico, y un solvente volatil; y su uso para tratar psoriasis, micosis entre otras enfermedades.
TW200716628A (en) Novel compounds
ECSP088763A (es) Nuevas combinaciones terapéuticas para el tratamiento de la depresión
DK1962815T3 (da) Anvendelse af filmdannende hårplejepolymerer fra gruppen polyurethaner og farmaceutiske tilberedninger og plastre indeholdende nævnte polymerer
NI201000015A (es) Bromhidrato de bupropión y aplicaciones terapéuticas
MX2010005012A (es) Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
CL2008002545A1 (es) Compuestos derivados de fenoxi-bencil-carbamoilo; composicion farmaceutica; procedimiento para preparar la composicion farmaceutica; y su uso en el tratamiento del dolor.
CL2008000495A1 (es) Compuestos derivados de tetrahidro-pirazolo[4,3-c]piridina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como alergias, inflamacion, dolor, cancer, entreotras.
ATE531703T1 (de) Benzochromenderivate
DK1713438T3 (da) Medicinsk sæbe

Legal Events

Date Code Title Description
FB Suspension of granting procedure